Challenges in the care and treatment of patients with extreme obesity
Open Access
- 18 July 2024
- journal article
- review article
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 68, e230335
Abstract
Obesity is a prevalent chronic disease. The management of extreme obesity – i.e., body mass index (BMI) ≥ 50 kg/m2 or obesity class IV and V – is still far from ideal. Individuals with extreme obesity have a high risk of surgical complications, mortality, comorbidities, and reduced weight loss following bariatric surgery. Although lifestyle changes and anti-obesity medications are recommended for all patients with extreme obesity as adjuvants to weight loss, these measures are less effective than bariatric surgery. [...] ABSTRACT Obesity is a prevalent chronic disease. The management of extreme obesity – i.e., body mass index (BMI) ≥ 50 kg/m2 or obesity class IV and V – is still far from ideal. Individuals with extreme obesity have a high risk of surgical complications, mortality, comorbidities, and reduced weight loss following bariatric surgery. Although lifestyle changes and anti-obesity medications are recommended for all patients with extreme obesity as adjuvants to weight loss, these measures are less effective than bariatric surgery.Keywords
This publication has 93 references indexed in Scilit:
- Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic SurgeryJAMA Surgery, 2023
- Efficacy and Safety of Rivaroxaban for Postoperative Thromboprophylaxis in Patients After Bariatric SurgeryJAMA Network Open, 2023
- Effectiveness of semaglutide versus liraglutide for treating post‐metabolic and bariatric surgery weight recurrenceObesity, 2023
- Impact of preoperative weight loss achieved by gastric balloon on peri- and postoperative outcomes of bariatric surgery in super-obese patients: a retrospective matched-pair analysisLangenbeck's Archives of Surgery, 2022
- Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 UpdateWorld Journal of Surgery, 2022
- Ten year comparative analysis of sleeve gastrectomy, Roux-en-Y gastric bypass, and biliopancreatic diversion with duodenal switch in patients with BMI ≥ 50 kg/m2Surgical Endoscopy, 2021
- Surgery in Patients with Super Obesity: Medium‐Term Follow‐Up Outcomes at a High‐Volume CenterObesity, 2019
- Bridging interventions before bariatric surgery in patients with BMI ≥ 50 kg/m2: a systematic review and meta-analysisSurgical Endoscopy, 2019
- Comparison of mini-gastric bypass with sleeve gastrectomy in a mainly super-obese patient group: first resultsSurgical Endoscopy, 2016
- Randomized clinical trial of laparoscopic gastric bypass versus laparoscopic duodenal switch for superobesityBritish Journal of Surgery, 2010